These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20117087)

  • 1. The role of MT2-MMP in cancer progression.
    Ito E; Yana I; Fujita C; Irifune A; Takeda M; Madachi A; Mori S; Hamada Y; Kawaguchi N; Matsuura N
    Biochem Biophys Res Commun; 2010 Mar; 393(2):222-7. PubMed ID: 20117087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice.
    Nyalendo C; Beaulieu E; Sartelet H; Michaud M; Fontaine N; Gingras D; Béliveau R
    Carcinogenesis; 2008 Aug; 29(8):1655-64. PubMed ID: 18621744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors.
    Ueda J; Kajita M; Suenaga N; Fujii K; Seiki M
    Oncogene; 2003 Nov; 22(54):8716-22. PubMed ID: 14647466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
    Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D
    Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
    Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
    Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
    Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P
    Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP.
    Robinet A; Fahem A; Cauchard JH; Huet E; Vincent L; Lorimier S; Antonicelli F; Soria C; Crepin M; Hornebeck W; Bellon G
    J Cell Sci; 2005 Jan; 118(Pt 2):343-56. PubMed ID: 15632106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression.
    Bonnomet A; Polette M; Strumane K; Gilles C; Dalstein V; Kileztky C; Berx G; van Roy F; Birembaut P; Nawrocki-Raby B
    Oncogene; 2008 Jun; 27(26):3692-9. PubMed ID: 18223680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
    Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
    Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.
    Yoshikawa T; Yanoma S; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Miyagi Y; Morinaga S; Noguchi Y; Yamamoto Y
    Hepatogastroenterology; 2006; 53(72):964-7. PubMed ID: 17153464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM; Kim A; Oh JH; Chung AS
    Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice.
    Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I
    Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
    Yamamoto H; Noura S; Okami J; Uemura M; Takemasa I; Ikeda M; Ishii H; Sekimoto M; Matsuura N; Monden M; Mori M
    Int J Mol Med; 2008 Dec; 22(6):757-61. PubMed ID: 19020773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.